Mersana Therapeutics
MRSN
$3.46
Share price
2.98%
Change (1 day)
-45.94%
Change (1 year)
Categories
Operating Margin for Mersana Therapeutics (MRSN)
Operating Margin as of May 2024 (TTM): -768.26%
According to Mersana Therapeutics's latest financial reports and stock price the company's current Operating Margin is -768.26%. At the end of 2021 the company had an Operating Margin of -395,488.37%.
Operating Margin history for Mersana Therapeutics from 2016 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -395,488.37% | 3619.28% |
| 2020 | -10,633.45% | 15778.93% |
| 2019 | -66.97% | -88.96% |
| 2018 | -606.54% | 174.93% |
| 2017 | -220.62% | 305.34% |
| 2016 | -54.43% | -65.68% |
| 2015 | -158.59% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.